Development and Validation of a Prognostic Signature Based on Immune Genes in Cervical Cancer

Development and Validation of a Prognostic Signature Based on Immune Genes in Cervical Cancer

BackgroundCervical cancer is one of the most common types of gynecological malignancies worldwide. This study aims to develop an immune signature to predict survival in cervical cancer.MethodThe gene expression data of 296 patients with cervical cancer from The Cancer Genome Atlas database (TCGA) an...

Full description

Bibliographic Details
Main Authors: Yu Chen, Hao Lin, Ya-Nan Pi, Xi-Xi Chen, Hu Zhou, Yuan Tian, Wei-Dong Zhao, Bai-Rong Xia
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-03-01
Series:Frontiers in Oncology
Subjects:
cervical cancer
immune signature
immune-based prognostic score
immune genes
prognostic signature
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.616530/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2021.616530/full

Similar Items